A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

Mise à jour : Il y a 4 ans
Référence : NCT01464021

Femme et Homme

  • | Pays :
  • China
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

A post-marketing uncontrolled observational study to explore and describe the effectiveness of adalimumab, as prescribed according to the local product label, in patients with moderately to severely active rheumatoid arthritis (RA) in China.


Critère d'inclusion

  • Arthritis ,Rheumatoid

Liens